上网科学工具app

上网科学工具app

Male Apellis employee holding a horse saddle

Luis
Supply Chain at Apellis

上网科学工具app

Learn More
Folded page of a newspaper

上网科学工具app

上网科学工具app

Apellis Pharmaceuticals Reports Second Quarter 2023 Financial Results

上网科学工具app

Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA)

w加速器官网

Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

Newsroom
w加速器安卓

@ApellisPharma

A man with a baby in a baby carrier

上网科学工具app

FOR PATIENTS
Erlenmeyer flask, which represents the pre-clinical and clinical studies sponsored by Apellis Pharmaceuticals

上网科学工具app

for paroxysmal nocturnal hemoglobinuria, geographic atrophy,
C3 glomerulopathy, and cold agglutinin disease.

PIPELINE
3 arrows of different lengths, which represents the development status of pre-clinical and clinical studies for C3 complement targeted therapies

上网科学工具app

are targeted C3 therapies. These include potential medicines for a broad range of serious diseases driven by uncontrolled or excessive activation of the complement system.

CLINICAL TRIALS

上网科学工具app

so that Alexander, who is living with C3 glomerulopathy, can take his pug for a hike

We challenge conventional thinking and always question if there's a better way.

Join Us
w加速器app

Patricia
Quality Assurance at Apellis

最快最干净在线代理网页  代理海外ip软件  蘑菇加速  佛跳墙极光下载  极光电脑加速器一年多少钱  快连版本  海归VPN  知乎梯子推荐